UnitedHealth Group Continues Efforts to Combat COVID-19, Reports Second Quarter Performance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
United Health (UNH) Results Show Diverse Businesses Set to Manage COVID Well - Mizuho Securities
July 15, 2020 11:49 AM EDTMizuho Securities analyst Ann Hynes reiterated a Buy rating and $315.00 price target on UnitedHealth Group (NYSE: UNH) following results, citing strong growth in Medicare/Medicaid offsetting soft commercial trends, Optum revenue, and an uptick in medical utilization and annuity.
The analyst stated... More
UnitedHealth Group (UNH) Tops Q2 EPS by $1.94, Revenues Miss; Maintains FY20 EPS Mid-Point Guidance Above Consensus
July 15, 2020 5:58 AM EDTUnitedHealth Group (NYSE: UNH) reported Q2 EPS of $7.12, $1.94 better than the analyst estimate of $5.18. Revenue for the quarter came in at $62.1 billion versus the consensus estimate of $63.43 billion.
UnitedHealth Groups second quarter 2020 revenues increased $1.5 billion to $62.1 billion, reflecting growth at Optum and the UnitedHealthcare public-sector and senior businesses, partially offset by economic-related impacts at UnitedHealthcare commercial and global.Second quarter earnings from operations increased $4.5 billion to $9.2 billion, impacted primarily by the previously described deferred care in the risk-based businesses, with this care expected to be delivered in future... More